FI
Fosun International Portfolio holdings
AUM
$360M
This Quarter Return
+12.61%
1 Year Return
+38.28%
3 Year Return
+3.77%
5 Year Return
+27.59%
10 Year Return
+94.55%
AUM
$1.57B
AUM Growth
+$1.57B
(-6%)
Cap. Flow
-$265M
Cap. Flow
% of AUM
-16.83%
Top 10 Holdings %
Top 10 Hldgs %
52.85%
Holding
343
New
45
Increased
88
Reduced
68
Closed
37
Top Buys
| 1 |
BZUN
Baozun
BZUN
|
$20.3M |
| 2 |
MOMO
Hello Group
MOMO
|
$6.36M |
| 3 |
Bristol-Myers Squibb
BMY
|
$3.97M |
| 4 |
BBU
Brookfield Business Partners
BBU
|
$3.38M |
| 5 |
Neurocrine Biosciences
NBIX
|
$3.34M |
Top Sells
| 1 |
KANG
iKang Healthcare Group, Inc.
KANG
|
$94.3M |
| 2 |
Vipshop
VIPS
|
$53.6M |
| 3 |
DigitalBridge
DBRG
|
$37.5M |
| 4 |
Brookdale Senior Living
BKD
|
$33.9M |
| 5 |
Criteo
CRTO
|
$15.3M |
Sector Composition
| 1 | Healthcare | 37.62% |
| 2 | Financials | 6.46% |
| 3 | Consumer Discretionary | 4.13% |
| 4 | Industrials | 2.9% |
| 5 | Communication Services | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
76
DELISTED
Zogenix, Inc.
ZGNX
| $2.49M | 0.16% |
45,700
| – | – |
|
|
QTNT
77
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $2.45M | 0.16% |
+6,831
| New | +$2.45M |
|
|
RARX
78
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $2.42M | 0.15% |
108,073
| – | – |
|
79
Theravance Biopharma
TBPH
$691M
| $2.39M | 0.15% |
+104,465
| New | +$2.39M |
|
80
Abbott
ABT
$230B
| $2.37M | 0.15% |
29,885
| – | – |
|
81
Sociedad Química y Minera de Chile
SQM
$12.5B
| $2.36M | 0.15% |
62,000
+5,000
| +9% | +$190K |
|
82
Wave Life Sciences
WVE
$1.27B
| $2.24M | 0.14% |
+59,088
| New | +$2.24M |
|
83
PayPal
PYPL
$66.5B
| $2.19M | 0.14% |
21,058
+2,038
| +11% | +$212K |
|
|
PGNX
84
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $2.17M | 0.14% |
472,580
+17,992
| +4% | +$82.8K |
|
85
Opko Health
OPK
$1.1B
| $2.17M | 0.14% |
858,142
+90,000
| +12% | +$228K |
|
|
EIDX
86
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $2.17M | 0.14% |
94,270
| – | – |
|
87
Garmin
GRMN
$45.6B
| $2.14M | 0.14% |
25,000
-12,700
| -34% | -$1.09M |
|
88
AnaptysBio
ANAB
$630M
| $2.12M | 0.13% |
30,696
+9,100
| +42% | +$629K |
|
89
Starbucks
SBUX
$99.2B
| $2.1M | 0.13% |
28,425
+14,825
| +109% | +$1.1M |
|
90
Viatris
VTRS
$12.3B
| $2.07M | 0.13% |
73,160
-38,631
| -35% | -$1.09M |
|
91
KalVista Pharmaceuticals
KALV
$713M
| $2.03M | 0.13% |
72,606
-64,837
| -47% | -$1.81M |
|
92
UBS Group
UBS
$126B
| $2.02M | 0.13% |
+170,925
| New | +$2.02M |
|
93
Bath & Body Works
BBWI
$6.3B
| $1.99M | 0.13% |
89,250
-515,764
| -85% | -$11.5M |
|
94
Cytokinetics
CYTK
$5.98B
| $1.98M | 0.13% |
239,792
+62,000
| +35% | +$512K |
|
|
EIGR
95
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.97M | 0.13% |
4,840
-1,220
| -20% | -$497K |
|
96
Apple
AAPL
$3.54T
| $1.92M | 0.12% |
40,628
-8,372
| -17% | -$396K |
|
97
KALA BIO
KALA
$105M
| $1.9M | 0.12% |
4,925
| – | – |
|
98
Merck
MRK
$210B
| $1.84M | 0.12% |
23,297
-68,801
| -75% | -$5.43M |
|
99
Blackrock
BLK
$170B
| $1.82M | 0.12% |
4,290
+3,640
| +560% | +$1.55M |
|
100
SL Green Realty
SLG
$4.16B
| $1.8M | 0.11% |
20,660
| – | – |
|